AGIO [NASD]
Agios Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-6.39 Insider Own0.50% Shs Outstand54.56M Perf Week-6.02%
Market Cap1.06B Forward P/E- EPS next Y-6.22 Insider Trans-0.31% Shs Float54.07M Perf Month-13.71%
Income-360.40M PEG- EPS next Q-1.69 Inst Own- Short Float11.08% Perf Quarter-36.30%
Sales0.80M P/S1326.63 EPS this Y-23.60% Inst Trans0.79% Short Ratio10.23 Perf Half Y-45.60%
Book/sh22.13 P/B0.90 EPS next Y5.40% ROA-23.50% Target Price39.40 Perf Year-64.45%
Cash/sh17.26 P/C1.15 EPS next 5Y39.00% ROE-26.00% 52W Range19.18 - 62.15 Perf YTD-39.67%
Dividend- P/FCF- EPS past 5Y-3.10% ROI- 52W High-68.10% Beta1.50
Dividend %- Quick Ratio21.20 Sales past 5Y- Gross Margin59.30% 52W Low3.39% ATR1.47
Employees390 Current Ratio21.30 Sales Q/Q- Oper. Margin- RSI (14)37.07 Volatility5.76% 7.24%
OptionableYes Debt/Eq0.00 EPS Q/Q-32.90% Profit Margin- Rel Volume0.91 Prev Close19.39
ShortableYes LT Debt/Eq0.00 EarningsMay 05 BMO Payout- Avg Volume585.61K Price19.83
Recom2.40 SMA20-8.11% SMA50-21.94% SMA200-43.38% Volume533,726 Change2.27%
Dec-03-21Initiated BofA Securities Buy $54
Jul-30-21Downgrade Goldman Neutral → Sell $58 → $39
Jul-01-21Initiated Raymond James Mkt Perform
Jun-10-21Initiated H.C. Wainwright Buy $88
Mar-01-21Upgrade SVB Leerink Mkt Perform → Outperform $50
Mar-01-21Downgrade JP Morgan Overweight → Neutral $64 → $54
Feb-26-21Downgrade SVB Leerink Outperform → Mkt Perform
Oct-22-20Upgrade Barclays Equal Weight → Overweight $46
Mar-04-20Initiated Barclays Equal Weight $50
Nov-26-19Initiated Cantor Fitzgerald Overweight $64
Sep-23-19Upgrade Guggenheim Neutral → Buy $55
May-23-19Resumed Goldman Neutral $55
Feb-15-19Upgrade SVB Leerink Mkt Perform → Outperform $80
Sep-25-18Initiated Leerink Partners Mkt Perform
May-23-18Initiated Citigroup Buy $117
Apr-11-18Reiterated Credit Suisse Outperform $80 → $95
Feb-15-18Reiterated SunTrust Buy $80 → $101
Feb-15-18Reiterated Needham Buy $72 → $86
Sep-15-17Initiated RBC Capital Mkts Outperform $78
Aug-10-17Reiterated Needham Buy $54 → $72
May-17-22 12:13PM  
May-16-22 04:15PM  
04:15PM  
May-12-22 10:00AM  
May-10-22 07:00AM  
May-07-22 09:02AM  
May-05-22 08:15AM  
07:00AM  
Apr-27-22 02:57PM  
Apr-21-22 07:00AM  
Apr-14-22 08:34AM  
Mar-01-22 08:35AM  
Feb-28-22 07:00AM  
Feb-24-22 05:49PM  
12:03PM  
08:55AM  
07:00AM  
Feb-23-22 12:57PM  
Feb-18-22 10:29AM  
05:41AM  
Feb-17-22 03:41PM  
03:03PM  
Feb-10-22 07:00AM  
Feb-08-22 01:38PM  
Jan-18-22 02:57PM  
Jan-10-22 01:38PM  
07:00AM  
Dec-22-21 07:00AM  
Dec-21-21 04:27AM  
Dec-17-21 11:38PM  
Dec-14-21 09:17AM  
Dec-13-21 06:15PM  
10:30AM  
07:00AM  
Dec-03-21 11:31AM  
Nov-15-21 04:01PM  
Nov-04-21 09:00AM  
06:30AM  
Nov-03-21 02:30PM  
01:27PM  
08:35AM  
07:11AM  
Oct-29-21 11:38AM  
06:22AM  
Oct-27-21 03:03PM  
Oct-21-21 04:01PM  
Oct-14-21 06:30AM  
Aug-30-21 07:00AM  
Aug-24-21 09:00AM  
Aug-18-21 10:05AM  
07:37AM  
Aug-17-21 04:01PM  
Jul-31-21 03:13AM  
Jul-30-21 12:10PM  
Jul-29-21 05:00PM  
08:25AM  
07:00AM  
Jul-22-21 03:03PM  
Jul-19-21 12:16PM  
Jul-15-21 07:00AM  
Jun-29-21 11:15AM  
Jun-28-21 07:00AM  
Jun-25-21 03:44PM  
Jun-23-21 01:11PM  
Jun-22-21 11:45AM  
07:00AM  
Jun-21-21 11:07AM  
07:00AM  
Jun-18-21 09:58AM  
Jun-11-21 03:00AM  
03:00AM  
May-12-21 10:00AM  
09:32AM  
May-02-21 03:08AM  
Apr-30-21 08:46AM  
Apr-29-21 06:30PM  
09:25AM  
07:00AM  
05:45AM  
Apr-22-21 12:33PM  
Apr-20-21 11:56AM  
Apr-15-21 07:00AM  
Apr-01-21 07:00AM  
Mar-27-21 11:31AM  
Mar-25-21 04:01PM  
Mar-18-21 07:00AM  
Mar-01-21 07:00AM  
Feb-27-21 01:04AM  
Feb-26-21 10:04AM  
09:21AM  
07:00AM  
Feb-25-21 07:00PM  
07:00AM  
06:15AM  
Feb-23-21 07:00AM  
Feb-11-21 07:00AM  
Feb-04-21 11:54PM  
Jan-27-21 07:35AM  
Jan-26-21 04:01PM  
Jan-17-21 10:00AM  
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scadden DavidDirectorMay 20Option Exercise0.001,58507,120May 24 04:12 PM
Clancy Paul JDirectorMay 20Option Exercise0.001,58506,549May 24 04:13 PM
Schenkein David PDirectorMay 20Option Exercise0.001,5850117,879May 24 04:11 PM
CLARK IAN TDirectorMay 20Option Exercise0.001,58506,549May 24 04:12 PM
Foster-Cheek Kaye IDirectorMay 20Option Exercise0.001,58508,749May 24 04:10 PM
MARAGANORE JOHNDirectorMay 20Option Exercise0.001,585030,028May 24 04:10 PM
Ho MaykinDirectorMay 20Option Exercise0.001,58506,549May 24 04:11 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 25Sale30.001083,2402,549Mar 01 04:54 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 22Option Exercise0.0016702,716Feb 23 04:09 PM
Schenkein David PDirectorFeb 22Option Exercise0.002,7750117,052Feb 23 04:09 PM
Burns James WilliamChief Legal OfficerFeb 22Option Exercise0.00724015,008Feb 23 04:10 PM
Poddar RichaChief Commercial OfficerFeb 22Option Exercise0.0065805,183Feb 23 04:11 PM
Gheuens SarahChief Medical OfficerFeb 18Option Exercise0.003,27108,723Feb 23 04:12 PM
Poddar RichaChief Commercial OfficerFeb 18Option Exercise0.001,88404,525Feb 23 04:11 PM
FOUSE JACQUALYN AChief Executive OfficerFeb 18Option Exercise0.0012,379078,571Feb 23 04:10 PM
Biller JonathanChief Financial OfficerFeb 18Option Exercise0.008,523025,641Feb 23 04:10 PM
Car BruceChief Scientific OfficerFeb 18Option Exercise0.006,874018,793Feb 23 04:11 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 16Sale30.812337,1792,549Feb 18 04:56 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 14Option Exercise0.0036003,413Feb 16 05:00 PM
Poddar RichaChief Commercial OfficerFeb 14Option Exercise0.001,73803,231Feb 16 05:00 PM
Burns James WilliamChief Legal OfficerFeb 14Option Exercise0.006,988016,439Feb 16 05:01 PM
FOUSE JACQUALYN AChief Executive OfficerFeb 14Option Exercise0.0011,334069,697Feb 16 05:01 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 14Sale31.2550415,7502,782Feb 16 05:00 PM
Biller JonathanChief Financial OfficerFeb 10Option Exercise0.003,667018,467Feb 14 04:08 PM
Burns James WilliamChief Legal OfficerFeb 10Option Exercise0.001,833010,094Feb 14 04:06 PM
Poddar RichaChief Commercial OfficerFeb 10Option Exercise0.002,06802,218Feb 14 04:06 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 10Option Exercise0.0077703,292Feb 14 04:08 PM
Gheuens SarahChief Medical OfficerFeb 10Option Exercise0.002,16206,210Feb 14 04:09 PM
Car BruceChief Scientific OfficerFeb 10Option Exercise0.003,667012,992Feb 14 04:07 PM
Car BruceChief Scientific OfficerJan 06Option Exercise0.003,437010,530Jan 10 04:06 PM
Biller JonathanChief Financial OfficerDec 03Option Exercise0.005,753016,623Dec 07 04:18 PM
Gheuens SarahChief Medical OfficerDec 02Option Exercise0.0083404,296Dec 07 04:18 PM
Alenson CarmanPrincipal Accounting OfficerJun 21Option Exercise51.511,77791,5331,777Jun 23 05:28 PM
Alenson CarmanPrincipal Accounting OfficerJun 21Sale61.611,777109,4810Jun 23 05:28 PM
Bowden ChristopherChief Medical OfficerJun 18Option Exercise49.9948,4932,423,99163,980Jun 22 04:44 PM
Bowden ChristopherChief Medical OfficerJun 18Sale60.1148,4932,914,85115,487Jun 22 04:44 PM
Bowden ChristopherChief Medical OfficerJun 17Option Exercise39.762,50299,48017,989Jun 21 04:18 PM
Bowden ChristopherChief Medical OfficerJun 17Sale60.022,502150,17015,487Jun 21 04:18 PM
Bowden ChristopherChief Medical OfficerJun 10Option Exercise39.7620,853829,11536,340Jun 11 05:00 PM
Bowden ChristopherChief Medical OfficerJun 10Sale60.0620,8531,252,43715,487Jun 11 05:00 PM
Bowden ChristopherChief Medical OfficerJun 09Option Exercise39.767,149284,24422,636Jun 11 05:00 PM
Bowden ChristopherChief Medical OfficerJun 09Sale60.167,149430,11715,487Jun 11 05:00 PM
Bowden ChristopherChief Medical OfficerJun 08Option Exercise39.766,675265,39822,162Jun 09 04:06 PM
Bowden ChristopherChief Medical OfficerJun 08Sale60.076,675400,93915,487Jun 09 04:06 PM
Bowden ChristopherChief Medical OfficerJun 07Option Exercise39.764,268169,69619,755Jun 09 04:06 PM
Bowden ChristopherChief Medical OfficerJun 07Sale60.044,268256,23215,487Jun 09 04:06 PM